Resectable Esophageal Cancer
7 clinical trials · Condition
◉ Watch Resectable Esophageal Cancer
| Record | Firm | Date |
|---|---|---|
| Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection (NCT05307835) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-12-02 |
| Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer (NCT04006041) | Jianhua Fu | 2019-06-25 |
| Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer (NCT03490292) | University of Wisconsin, Madison | 2018-05-29 |
| Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer (NCT01858805) | Universitätsklinikum Hamburg-Eppendorf | 2010-04-01 |
| Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma (NCT00827671) | P.O. Witteveen | 2009-03-01 |
Track Resectable Esophageal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.